1. Market Research
  2. > Biotechnology
  3. > Genomics Market Trends
  4. > miRNA Research and Diagnostics Markets

miRNA Research and Diagnostics Markets

  • September 2014
  • -
  • Kalorama Information
  • -
  • 200 pages

Summary

Table of Contents

Search Inside

This report considers the diagnostic promise of non-coding RNA molecules, with a particular focus on the microRNAs. miRNAs (MicroRNAs) are short, single stranded RNAs that regulate mRNA expression at the post-transcriptional level. These small bits of RNA, members of a class of non-translated molecules that do not produce protein, shut off gene transcription by base pairing with the target molecules. They are now recognized as pivotal regulators of gene expression; including development, proliferation, differentiation, and apoptosis and serving widespread functions as regulatory molecules in post-transcriptional gene silencing. As the report details, a large number of companies, both small biotechs and big pharmaceutical companies are committed to miRNA diagnostics.

As part of its coverage of this topic, this report includes the following:
Overview of miRNAs
Positive Factors for miRNA Diagnostic Technologies
Negative Factors
miRNAs and Neurological Disorders
miRNA and Metastatic Brain Lesions
Prostate Cancer Screening and miRNAs
miRNAs and Resistance to Anti-Cancer Drugs
Theoretical Limitations
Discussion of Patent Issues
Interviews with Industry Experts
Market Estimate

One the positive side of the equation, the technology is innovative, and offers the promise of non-invasive diagnostics for cancer and other disorders that could be cheaper, faster and more accurate than existing tests, which are either non-existent or leave much to be desired. On the negative side of the equation, there are many complex challenges that must be resolved before the technology can be applicable. There is a need for large scale clinical trials, and rigorous standardization of the assay conditions, given the fact that the assessments of serum levels of miRNA molecules are quantitative. This report considers the potential for the miRNA market in research and diagnostics and the challenges. In doing so, the report looks at several companies currently developing research and diagnostic miRNA technologies.

As part of its coverage, the miRNA offerings and products in developments in the following companies are profiled in detail.
Agilent Technologies
Alnylam
AMSBIO
Applied Biosystems
Asuragen
DiamiR, LLC
Dicerna
Eisai Biomarkers and Personalized Medicine
Diagnostics
Exiqon
Genomic Health Inc.
Gensignia
GlaxoSmithKline Discovery and Molecular Toxicology
Groove Biopharma (formerly Mirina)
Hologic-Gen Probe Inc.
Illumina, Inc.
Isis Pharmaceuticals
Mello Biotechnology Inc.
Microlin Bio
MiRagen Therapeutics
MiRNA Therapeutics
Novartis
Pacific Edge Biotechnology
Prolias Technologies
Regulus Therapeutics
Rosetta Genomics
Santaris Pharma A/S
Sirnaomics, Inc.
Somagenics
Diagnostics: Small RNA Assays and Biomarker Validation
Tekmira Pharmaceuticals Corporation
Thermadiag
Thermo Fisher Scientific, Inc.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Non-alcoholic Steatohepatitis Biomarkers Market and Pharmaceutical Industry, Academic Research Institute, Hospitals, and Diagnostic Laboratories - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Non-alcoholic Steatohepatitis Biomarkers Market and Pharmaceutical Industry, Academic Research Institute, Hospitals, and Diagnostic Laboratories - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • January 2017
  • by Transparency Market Research

Global Non-alcoholic Steatohepatitis Biomarker Market: Overview Non-alcoholic steatohepatitis (NASH) is liver disease which is categorized under the spectrum of non-alcoholic fatty liver disease (NAFLD). ...

Biomarkers Market by Product, Type, Disease Indication, Application - Global Forecast to 2021

Biomarkers Market by Product, Type, Disease Indication, Application - Global Forecast to 2021

  • $ 5650
  • Industry report
  • February 2017
  • by MarketsandMarkets

The global biomarkers market is estimated to reach USD 53.34 billion by 2021 from USD 27.95 billion in 2016, at a CAGR of 13.8% from 2016 to 2021. Increasing diagnostic applications of biomarkers, increasing ...

Next-Generation Sequencing (NGS) Market by Product (Hiseq, Miseq, Hiseq X Ten/X Five, NextSeq500, Ion Proton, PGM, Ions5, PacBio RSII), Services (Targeted, RNA, Exome, De Novo), & Application (Diagnostics, Biomarker, Agriculture) - Global Forecasts to 202

Next-Generation Sequencing (NGS) Market by Product (Hiseq, Miseq, Hiseq X Ten/X Five, NextSeq500, Ion Proton, PGM, Ions5, PacBio RSII), Services (Targeted, RNA, Exome, De Novo), & Application (Diagnostics, Biomarker, Agriculture) - Global Forecasts to 202

  • $ 5650
  • Industry report
  • April 2017
  • by MarketsandMarkets

The global next-generation sequencing market is estimated to register a CAGR of 20.5% from 2017 to 2022 to reach USD 12.45 billion by 2022. Factors such as technological advancements in NGS platforms, ...


Download Unlimited Documents from Trusted Public Sources

Genomics Industry in the US

  • March 2017
    8 pages
  • Genomics  

  • United States  

    Asia  

View report >

Genetic Industry in Australia

  • February 2017
    79 pages
  • Genetic  

    Health Care Pro...  

    Clinic  

  • Australia  

View report >

Cancer Statistics

  • February 2017
    6 pages
  • Cancer  

  • United Kingdom  

    United States  

View report >

Oleochemicals Industry

3 months ago

Related Market Segments :

Biomarker
Cancer
Diagnostic Imaging
HIV Antiviral

ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.